CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Merck KGaA (ADR) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Merck KGaA (ADR)
Frankfurter Str. 250
Phone: +49 6151720p:+49 6151720 DARMSTADT, 64293  Germany Ticker: MKKGYMKKGY
Business Summary
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes--Yes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2836 Biological products, except diagnostic substances
3845 Electromedical and electrotherapeutic apparatus
8731 Commercial physical and biological research
3679 Electronic components, not elsewhere classified
2819 Industrial inorganic chemicals, not elsewhere classified
3674 Semiconductors and related devices

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Supervisory Board WolfgangBuechele 63 5/9/2014 7/1/2009
Chairman of the Executive Board, Chief Executive Officer BelenGarijo 62 5/1/2021 1/1/2015
Vice Chairman of the Supervisory Board SaschaHeld 40 5/28/2020 4/26/2019
9 additional Officers and Directors records available in full report.

Business Names
Business Name
Erbi Biosystems, Inc.
Exelead, Inc.
MKKGY

General Information
Number of Employees: 63,712 (As of 6/30/2023)
Outstanding Shares: 434,777,878 (As of 6/30/2023)
Stock Exchange: OTC
Fax Number: +49 6151722000


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 2, 2023